Bioventus (BVS) Other Non-Current Liabilities (2021 - 2026)

Bioventus' Other Non-Current Liabilities history runs 6 years deep, the most recent figure standing at $14.3 million for Q1 2026.

• Quarterly Other Non-Current Liabilities fell 35.02% year-over-year to $14.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $14.3 million (down 35.02% YoY) and the FY2025 annual result came in at $15.3 million, down 33.56% from the prior year.
• Other Non-Current Liabilities was $14.3 million for Q1 2026 at Bioventus, down from $15.3 million in the prior quarter.
• Across five years, Other Non-Current Liabilities topped out at $30.9 million in Q3 2023 and bottomed at $14.3 million in Q1 2026.
• A 5-year average of $21.1 million and a median of $21.3 million in 2025 frame the typical range for Other Non-Current Liabilities.
• Annual changes were most pronounced in 2023 — Other Non-Current Liabilities jumped 60.25% — and 2026, when it sank 35.02%.
• Bioventus' Other Non-Current Liabilities stood at $17.4 million in 2022, then soared by 60.25% to $27.9 million in 2023, then decreased by 17.3% to $23.1 million in 2024, then sank by 33.56% to $15.3 million in 2025, then slipped by 6.93% to $14.3 million in 2026.
• Business Quant data shows BVS's Other Non-Current Liabilities at $14.3 million in Q1 2026, $15.3 million in Q4 2025, and $20.5 million in Q3 2025.